These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29573393)

  • 1. Automated scoring of vitiligo using superpixel-generated computerized digital image analysis of clinical photographs: a novel and consistent way to score vitiligo.
    Toh JJH; Bhoi S; Tan VWD; Chuah SY; Jhingan A; Kong AWK; Thng STG
    Br J Dermatol; 2018 Jul; 179(1):220-221. PubMed ID: 29573393
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation study of the Vitiligo Extent Score-plus.
    van Geel N; Wolkerstorfer A; Lommerts JE; Ezzedine K; Eleftheriadou V; Hamzavi I; Harris J; Picardo M; Taieb A; Prinsen CAC; Bekkenk M; Speeckaert R
    J Am Acad Dermatol; 2018 May; 78(5):1013-1015. PubMed ID: 29180094
    [No Abstract]   [Full Text] [Related]  

  • 3. Software for quantifying psoriasis and vitiligo from digital clinical photographs.
    Kislal EE; Halasz CL
    J Dermatolog Treat; 2013 Apr; 24(2):107-11. PubMed ID: 21801117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo.
    van Geel N; Bekkenk M; Lommerts JE; Ezzedine K; Harris J; Hamzavi I; Eleftheriadou V; Picardo M; Taieb A; Prinsen CAC; Wolkerstorfer A; Speeckaert R
    J Am Acad Dermatol; 2018 Aug; 79(2):369-371. PubMed ID: 29307645
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing serial photography for assessing and monitoring vitiligo: A core set of international recommendations for essential clinical and technical specifications.
    van Geel N; Hamzavi I; Kohli I; Wolkerstorfer A; Lim HW; Bae JM; Lui H; Harris JE; Pandya AG; Thng Tien Guan S; Abdallah M; Esmat S; Seneschal J; Speeckaert R; Grine L; Kang HY; Raboobee N; Xiang LF; Bekkenk M; Picardo M; Taieb A
    J Am Acad Dermatol; 2020 Dec; 83(6):1639-1646. PubMed ID: 31678332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A.
    Bukhari IA
    Saudi Med J; 2005 Dec; 26(12):2011; author reply 2011. PubMed ID: 16380801
    [No Abstract]   [Full Text] [Related]  

  • 8. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.
    Joshipura D; Alomran A; Zancanaro P; Rosmarin D
    J Am Acad Dermatol; 2018 Jun; 78(6):1205-1207.e1. PubMed ID: 29438765
    [No Abstract]   [Full Text] [Related]  

  • 10. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
    Natta R; Somsak T; Wisuttida T; Laor L
    J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.
    Benzekri L; Ezzedine K; Gauthier Y
    Br J Dermatol; 2013 May; 168(5):1143-6. PubMed ID: 23464539
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultraviolet light exerts a major part of its therapeutic efficacy against vitiligo by production of prostaglandin E2.
    Namazi MR
    Dermatology; 2008; 217(2):149. PubMed ID: 18523390
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients.
    Cabrera R; Hojman L; Recule F; Sepulveda R; Delgado I
    Acta Derm Venereol; 2018 Apr; 98(4):416-420. PubMed ID: 29362810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis.
    van Geel N; Vandendriessche D; Vandersichel E; De Schepper S; Grine L; Mertens L; Vandaele V; Spoelders F; Bekkenk M; Wolkerstorfer A; Prinsen CA; Speeckaert R
    Br J Dermatol; 2019 May; 180(5):1198-1205. PubMed ID: 30207606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Perspectives: What is Vitiligo?
    Pediatr Dermatol; 2015; 32(6):e328-9. PubMed ID: 26584709
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of vitiligo with narrow-band ultraviolet B: advantages and disadvantages.
    Abdulla SJ; Desgroseilliers JP
    J Cutan Med Surg; 2008; 12(4):174-9. PubMed ID: 18627697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose UVB therapy is comparable with conventional UVB phototherapy for treatment of vitiligo: A pilot study.
    Chiu SH; Liu IL; Chen YW; Lan CE
    J Dermatol Sci; 2018 Nov; 92(2):218-220. PubMed ID: 30227989
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative.
    van Geel N; Lommerts J; Bekkenk M; Wolkerstorfer A; Prinsen CAC; Eleftheriadou V; Taïeb A; Picardo M; Ezzedine K; Speeckaert R
    J Invest Dermatol; 2016 May; 136(5):978-984. PubMed ID: 26827762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent component analysis for assessing therapeutic response in vitiligo skin disorder.
    Fadzil MH; Norashikin S; Suraiya HH; Nugroho H
    J Med Eng Technol; 2009; 33(2):101-9. PubMed ID: 19205989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.